BORRELLI, ENRICO
 Distribuzione geografica
Continente #
EU - Europa 2.564
AS - Asia 2.028
NA - Nord America 1.833
SA - Sud America 399
AF - Africa 49
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.889
Nazione #
US - Stati Uniti d'America 1.721
RU - Federazione Russa 1.540
CN - Cina 707
SG - Singapore 603
IT - Italia 338
BR - Brasile 328
VN - Vietnam 239
SE - Svezia 233
HK - Hong Kong 207
FR - Francia 115
IN - India 80
DE - Germania 73
GB - Regno Unito 73
CA - Canada 69
FI - Finlandia 51
NL - Olanda 32
MX - Messico 30
JP - Giappone 29
PL - Polonia 28
BD - Bangladesh 27
AR - Argentina 25
ES - Italia 22
TR - Turchia 19
ZA - Sudafrica 19
IQ - Iraq 18
KR - Corea 17
ID - Indonesia 13
LT - Lituania 12
AT - Austria 11
CO - Colombia 11
NZ - Nuova Zelanda 11
BE - Belgio 10
MY - Malesia 10
PY - Paraguay 10
IE - Irlanda 9
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
SA - Arabia Saudita 8
EG - Egitto 7
MA - Marocco 7
NP - Nepal 6
PK - Pakistan 6
VE - Venezuela 6
AU - Australia 4
CL - Cile 4
DZ - Algeria 4
IL - Israele 4
JM - Giamaica 4
PH - Filippine 4
TN - Tunisia 4
CR - Costa Rica 3
KE - Kenya 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
HN - Honduras 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
RO - Romania 2
RS - Serbia 2
SD - Sudan 2
SN - Senegal 2
TJ - Tagikistan 2
UA - Ucraina 2
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
MK - Macedonia 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 6.889
Città #
Ashburn 360
Singapore 355
Moscow 300
San Jose 242
Hong Kong 196
Beijing 134
Shanghai 132
Dallas 121
New York 121
Hefei 85
Ho Chi Minh City 83
Los Angeles 78
Lauterbourg 74
Milan 64
Hanoi 62
Princeton 58
Lawrence 57
Santa Clara 38
São Paulo 36
Helsinki 29
Chennai 25
Orem 25
Tokyo 25
Warsaw 25
Montreal 24
Brooklyn 19
Council Bluffs 19
Poplar 18
Toronto 18
Atlanta 17
London 17
Phoenix 17
Boardman 16
Johannesburg 16
Mumbai 15
Ludhiana 14
Rome 14
Chicago 13
Houston 13
Denver 12
Gwanak-gu 12
Mexico City 12
Novlyanka 12
Nuremberg 12
Stockholm 12
Boston 11
Turku 11
Amsterdam 10
Ankara 10
Auckland 10
Frankfurt am Main 10
Guangzhou 10
Lappeenranta 10
Manchester 10
Shenzhen 10
Biên Hòa 9
Dublin 9
Hải Dương 9
Munich 9
Rio de Janeiro 9
The Dalles 9
Brussels 8
Kuala Lumpur 8
Seattle 8
Trento 8
Asunción 7
Belo Horizonte 7
Haiphong 7
Naples 7
Vienna 7
Bari 6
Barnet 6
Brasília 6
Cesano Boscone 6
Hanover 6
Jakarta 6
Ninh Bình 6
Piracicaba 6
San Francisco 6
San Giovanni la Punta 6
Tianjin 6
Baghdad 5
Bergamo 5
Brescia 5
Dhaka 5
Palermo 5
Philadelphia 5
Porto Alegre 5
Querétaro 5
Riyadh 5
Thái Nguyên 5
Washington 5
Zhengzhou 5
Catania 4
Columbus 4
Contagem 4
Curitiba 4
Da Nang 4
Dubai 4
Duque de Caxias 4
Totale 3.424
Nome #
OCULAR AND GENETIC CHARACTERISTICS OF PATIENTS SURVIVING LONG-LASTING TYPE 1 DIABETES WITHOUT VASCULAR COMPLICATIONS 176
Perifoveal exudative vascular anomalous complex in a highly myopic eye 139
CHOROIDAL VASCULARITY INDEX IN HYDROXYCHLOROQUINE TOXIC RETINOPATHY: A Quantitative Comparative Analysis Using Enhanced Depth Imaging In Spectral Domain Optical Coherence Tomography 133
Peripapillary hyperreflective ovoid mass-like structures (PHOMS) in patients with acute Leber's hereditary optic neuropathy 126
Photoreceptor alteration in intermediate age-related macular degeneration 118
Long-term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes with Diabetic Macular Edema treated with Anti-VEGF Therapy 118
Visual Outcomes and Optical Coherence Tomography Biomarkers of Vision Improvement in Patients With Leber Hereditary Optic Neuropathy Treated With Idebenone 117
Choroidal vascularity index in leptochoroid: A comparative analysis between reticular pseudodrusen and high myopia 112
Retinal neurodegeneration in age-related macular degeneration 109
Choroidal vascularity index in eyes with central macular atrophy secondary to age-related macular degeneration and Stargardt disease 109
Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study 106
Choriocapillaris flow impairment could predict the enlargement of geographic atrophy lesion 105
Capturing the Transition From Intermediate to Neovascular AMD: Longitudinal Inner Retinal Thinning and Factors Associated With Neuronal Loss 101
Choroidal vascularity index is associated with geographic atrophy progression 101
Choroidal vascularity index in hereditary optic neuropathies 97
Choroidal Rift: A New OCT Finding in Eyes with Central Serous Chorioretinopathy 97
Choroidal cleft simulating choroidal caverns in neovascular age-related macular degeneration 97
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ASSESSMENT OF THE DIABETIC MACULA: A Comparison Study Among Different Algorithms 96
CHOROIDAL AMYLOID DEPOSITION: A Multicenter Study of Amyloid Lesions Identified in Late Indocyanine Green Angiography 95
Spectrally Resolved Fundus Autofluorescence in Healthy Eyes: Repeatability and Topographical Analysis of the Green-Emitting Fluorophores 95
Retinal Thickness Deviation: A New OCT Parameter for Assessing Diabetic Macular Edema 91
Longitudinal follow-up and outcome analysis in central serous chorioretinopathy 91
Choroidal Neovascularization in a Patient with Crohn's Disease 90
Choroideremia: Update On Clinical Features And Emerging Treatments 90
Peripapillary hyperreflective ovoid mass-like structures (PHOMS): OCTA may reveal new findings 90
Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine 90
Imaging biomarkers and clinical factors associated with the rate of progressive inner and outer retinal thinning in patients with diabetic macular edema 89
In vivo rotational three-dimensional OCTA analysis of microaneurysms in the human diabetic retina 88
Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy 88
Complications associated with worse visual outcomes in patients with exudative neovascular age-related macular degeneration 86
Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect” 85
Choroidal luminal and stromal areas and choriocapillaris perfusion are characterised by a non-linear quadratic relation in healthy eyes 85
Deep-learning based automated quantification of critical optical coherence tomography features in neovascular age-related macular degeneration 84
Appearance of cysts and capillary non perfusion areas in diabetic macular edema using two different OCTA devices 84
Gliotic tissue simulating a macular neovascularization in full-thickness macular hole 84
Diabetic macular ischemia 83
Wolfram Syndrome: Only a Neurodegenerative Disease or Also a Maculopathy? 83
Individual vs. combined imaging modalities for diagnosing neovascular central serous chorioretinopathy 82
Changes in Choroidal Thickness follow the RNFL Changes in Leber’s Hereditary Optic Neuropathy 82
Choroidal thickness and the retinal ganglion cell complex in chronic Leberʼs hereditary optic neuropathy: a prospective study using swept-source optical coherence tomography 82
Prevalence and Morphologic Biomarkers of Metamorphopsia in eyes with "Resolved" Chronic Central Serous Chorioretinopathy 81
OCT-A characterisation of recurrent type 3 macular neovascularisation 81
Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic 81
Comparison Between Ultra-Widefield Pseudocolor Imaging and Indirect Ophthalmoscopy in the Detection of Peripheral Retinal Lesions 80
Multimodal imaging characterization of peripheral drusen 80
INNER AND OUTER CHOROIDAL CHANGES IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY 77
Nonmydriatic widefield retinal imaging with an automatic white LED confocal imaging system compared with dilated ophthalmoscopy in screening for diabetic retinopathy 77
Longitudinal evaluation of the development of wedge-shaped subretinal hyporeflectivity in geographic atrophy 76
One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study 76
Multimodal Imaging of Peripapillary hyperreflective ovoid mass-like structures (PHOMS) 75
Dimple in vascularized serous pigment epithelial detachment secondary to neovascular age-related macular degeneration 74
Complicated Retinal Pigment Epithelium Humps in High Myopia 73
Discerning Between Macular Hemorrhages Due to Macular Neovascularization or Due to Spontaneous Bruch’s Membrane Rupture in High Myopia: A Comparative Analysis Between OCTA and Fluorescein Angiography 73
The retinal neurovascular coupling is impaired in men with vasculogenic erectile dysfunction 72
Recognition, diagnosis and treatment of chorioretinal folds: Current perspectives 72
Spontaneous resolution of optic pit maculopathy: an OCT report 71
Nonexudative Perifoveal Vascular Anomalous Complex: The Subclinical Stage of Perifoveal Exudative Vascular Anomalous Complex? 70
Guidelines on Optical Coherence Tomography Angiography Imaging: 2020 Focused Update 68
Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy 67
Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease 66
OCTA characterisation of microvascular retinal alterations in patients with central serous chorioretinopathy 66
Multimodal Imaging Assessment of Vascular and Neurodegenerative Retinal Alterations in Type 1 Diabetic Patients without Fundoscopic Signs of Diabetic Retinopathy 66
Quantification of diabetic macular ischemia using novel three-dimensional optical coherence tomography angiography metrics 64
TriPla Regimen: A new treatment approach for patients with neovascular age-related macular degeneration in the COVID-19 "era" 62
Imaging Biomarkers of Mesopic and Dark-Adapted Macular Functions in Eyes With Treatment-Naïve Mild Diabetic Retinopathy 61
Emerging therapies in the management of macular edema: A review [version 1; peer review: 2 approved] 61
Quantitative Analysis of Choriocapillaris Using Swept-Source Optical Coherence Tomography Angiography in Eyes with Angioid Streaks 59
InCASEOf scoring system for distinction between pachychoroid-associated macular neovascularization and neovascular age-related macular degeneration in patients older than 50 years 59
Management of patients with diabetic macular oedema and good visual acuity: new findings from Protocol V 59
Rotational Three-dimensional OCTA: a Notable New Imaging Tool to Characterize Type 3 Macular Neovascularization 59
Impact of bleaching on photoreceptors in different intermediate AMD phenotypes 59
Morphofunctional analysis of the retina in patients with type 1 diabetes without complications after 30 years of disease 56
Symptomatic Vitreous Opacities: Exploring the Mismatch between Clinical Observation of Vitreous Alterations and Self-Reported Symptoms 55
Choroidal Hyperreflective Foci Represent a Common Finding Across Different Types of Macular Atrophy 55
Multimodal imaging to detect in vivo responses to aflibercept therapy in a mouse model of type 3 neovascularization 55
Subretinal pseudocysts: A novel OCT finding in diabetic macular edema 54
Neovascular age-related macular degeneration: advancement in retinal imaging builds a bridge between histopathology and clinical findings 53
PHOTORECEPTOR OUTER SEGMENT IS EXPANDED IN THE FELLOW EYE OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY 52
Reply to: Non-Exudative Perifoveal Vascular Anomalous Complex: the Subclinical Stage of Perifoveal Exudative Vascular Anomalous Complex? 52
Haller’s vessels patterns in non-neovascular age-related macular degeneration 52
Predictors of Macular Atrophy after Serous Pigment Epithelial Detachment Collapse in Type 3 Macular Neovascularization and Age-Related Macular Degeneration 50
Management of patients with macular oedema secondary to central retinal vein occlusion: new findings from SCORE2 and LEAVO studies 50
Optical coherence tomography angiography in diabetes: focus on microaneurysms 50
Retinal Telangiectasias Associated with Myelinated Nerve Fibers 48
Taking the right measures to control COVID-19 in ophthalmology: the experience of a tertiary eye care referral center in Italy 47
Structural reorganization of the ophthalmological practice in a COVID-19 hub hospital: experience from European epicenter of the pandemic 45
Optical coherence tomography angiography in diabetes: A review 45
Visual Performance and Predictive OCT Biomarkers in Epiretinal Membrane Assessment: Beyond Distance Visual Acuity 21
Structural OCT and OCT angiography biomarkers associated with the development and progression of geographic atrophy in AMD 12
Deep Learning in Neovascular Age-Related Macular Degeneration 9
Pushing Retinal Imaging Forward: Innovations and their Clinical Meaning. The 2022 Ophthalmologica Lecture 9
Distinct Pathways of Macular Atrophy in Type 3 Macular Neovascularization Associated With AMD 8
OCT risk factors for 2-year foveal involvement in non-treated eyes with extrafoveal geographic atrophy and AMD 7
Intersession repeatability of reading performance measures in patients with neovascular age-related macular degeneration 5
Validation of a deep learning model for automatic detection and quantification of five OCT critical retinal features associated with neovascular age-related macular degeneration 5
Mitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and management 5
The “triple-layer sign”: an optical coherence tomography signature for the detection of non-exudative macular neovascularization 5
Sectorial Ganglion Cell Complex Thickness as Biomarker of Vision Outcome in Patients With Dominant Optic Atrophy 5
Relationship of Topographic Distribution of Macular Atrophy Secondary to Neovascular AMD and Reading Performance 5
Ensuring the strict and accurate adherence to inclusion criteria in clinical trials for AMD is crucial 4
Totale 7.058
Categoria #
all - tutte 40.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.727


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202278 0 0 0 35 10 1 9 8 2 0 4 9
2022/2023423 136 95 29 8 1 46 12 22 40 19 4 11
2023/2024550 9 45 46 117 56 120 22 37 7 29 29 33
2024/20251.325 163 67 47 38 103 140 165 123 130 119 92 138
2025/20264.649 325 338 191 538 431 141 469 368 1.306 311 129 102
Totale 7.074